Weitere Symbole
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 6084 | AIQU | 20.97 USD | -4.51% | -7.05% | +20.24% | -14.69% | 0 USD | ||
| 6085 | CTJN | 25.17 USD | 0.00% | 0.00% | 0.00% | +0.12% | 0 USD | ||
| 6086 | HBMX | 24.32 USD | -2.95% | -7.25% | +12.49% | -5.74% | 0 USD | ||
| 6087 | HJUN | 25.35 USD | 0.00% | -0.12% | -0.08% | +0.88% | 0 USD | ||
| 6088 | NXPG | 7.08 USD | +0.14% | -12.48% | +0.28% | -55.19% | 0 USD | ||
| 6089 | ONG | 4.45 USD | -1.98% | -20.82% | +8.54% | -73.88% | 0 USD | ||
| 6090 | PRIZ | 24.66 USD | 0.00% | +0.24% | -1.12% | -1.48% | 0 USD | ||
| 6091 | QQJN | 25.40 USD | 0.00% | 0.00% | 0.00% | +0.99% | 0 USD | ||
| 6092 | RACK | 48.59 USD | -2.33% | -3.63% | +5.06% | -7.73% | 0 USD | ||
| 6093 | VSXY | 88.57 USD | +6.92% | -2.08% | +20.03% | +13.55% | 0 USD | ||
| 6094 | ZINC | 25.53 USD | +0.12% | +0.83% | -3.48% | +0.83% | 0 USD | ||
| 6095 | AADX | 10.94 USD | -4.54% | -7.21% | -9.36% | -47.28% | 0 USD | ||
| 6096 | ACGO | 39.61 USD | -0.08% | -1.15% | +5.68% | +0.56% | 0 USD | ||
| 6097 | BGEG | 23.21 USD | 0.00% | -3.25% | +0.78% | -8.22% | 0 USD | ||
| 6098 | BGIA | 25.20 USD | 0.00% | -1.22% | +0.68% | 0.00% | 0 USD | ||
| 6099 | BRZX | 35.42 USD | 0.00% | 0.00% | +28.05% | +51.37% | 0 USD | ||
| 6100 | EMXX | 23.60 USD | 0.00% | 0.00% | -1.54% | -1.91% | 0 USD | ||
| 6101 | EUVX | 14.46 USD | -8.77% | -16.75% | +18.23% | -39.62% | 0 USD | ||
| 6102 | INYY | 34.34 USD | -3.05% | -14.09% | -1.04% | -33.72% | 0 USD | ||
| 6103 | KRWX | 12.69 USD | -7.98% | -19.17% | -9.87% | -47.58% | 0 USD |
Nachrichten Weitere Symbole
Myomo ernennt Mary-Katherine McClure zur neuen Chief Commercial Officer
ArriVent: Erster Patient in Phase-1-Studie mit Krebsmedikament ARR-002 behandelt
Watsco übernimmt The Granite Group: BBH Capital Partners schließt Exit ab
Lattice Semiconductor stellt quantenresistente Sicherheitslösung vor
Cytokinetics: Neue Studiendaten untermauern Wirksamkeit von Aficamten
Syndax Pharmaceuticals: Aktie stürzt nach gescheiterter IPF-Studie ab
Syndax: Axatilimab verfehlt primären Endpunkt in Studie zu Lungenfibrose
Gainers Weitere Symbole
POAS Phaos Technology Holdings Limited Class A Ordinary Shares | 1.94 | +1285.71% |
WFF WF Holding Limited - Ordinary Shares | 25.23 | +105.29% |
SKYA | 2.61 | +43.41% |
ELOG Eastern International Ltd. - Ordinary Shares | 1.03 | +27.16% |
LITZ | 21.70 | +21.91% |
CBRZ | 14.12 | +19.76% |
BEZ | 5.46 | +14.47% |
SMZ | 24.20 | +13.40% |
Losers Weitere Symbole
DKI DarkIris Inc. - Class A Ordinary Shares | 0.14 | -58.82% |
PSIG PS International Group Ltd. - Ordinary Shares | 3.41 | -33.14% |
BGLWW Blue Gold Limited - Warrant | 0.0261 | -30.40% |
WCT Wellchange Holdings Company Limited - Class A Ordinary shares | 0.71 | -27.55% |
HDRN | 0.80 | -25.23% |
QUCY | 1.05 | -22.22% |
LITU | 20.94 | -21.92% |
CBRX | 5.33 | -21.04% |